« Return to News | Awards & Advancement

PharmaNet names Dr. Joel Posener executive medical director, neuroscience

Wednesday, June 29, 2011 12:47 PM

PharmaNet Development Group, a provider of clinical development services, has named Joel Posener, M.D., Executive Medical Director, Neuroscience.

Dr. Posener will support PharmaNet project teams conducting clinical trials in psychiatry and neurology and provide drug development advice to clients in neuroscience.

Previously, Dr. Posener held roles at Wyeth as senior director, neuroscience medical research and senior director, early development and clinical pharmacology. He directed phase II projects in psychiatric indications including cognitive impairment in schizophrenia, bipolar disorder and depression. Dr. Posener has also managed early clinical development programs in schizophrenia, depression and Alzheimer's disease.

Before joining the pharmaceutical industry, Dr. Posener served on the faculty of Harvard Medical School and Washington University School of Medicine in St. Louis, where he was also medical director of Metropolitan St. Louis Psychiatric Center. Dr. Posener currently holds an appointment as Clinical Associate Professor of Psychiatry at Temple University School of Medicine.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.